Trastuzumab combined with trimodality treatment does not improve outcomes for patients

Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival (DFS) outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma. These results were recently, orally presented during the virtual Annual Meeting of the American Society…

Details

Older men worry less than others about COVID-19

ATLANTA—Older men may be at greater risk of contracting COVID-19 because they worry less about catching or dying from it than women their age or than younger people of both sexes, according to a new study by Sarah Barber, a gerontology and psychology researcher at Georgia State University. This is a concern because older men…

Details

Using brain imaging to demonstrate weaker neural suppression for those with autism

MINNEAPOLIS, MN- May 29, 2020 — According to the National Autism Association, people with autism spectrum disorder (ASD) may experience sensory hypersensitivity. A University of Minnesota Medical School researcher recently published an article in Nature Communications that illustrates why that may be true by showing the differences in visual motion perception in ASD are accompanied…

Details

Combined cediranib and olaparib presents similar activity to standard of care treatment

Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy did not improve progression-free survival (PFS) outcomes for women with platinum-sensitive ovarian cancer;, however, activity between the treatments were similar in patients. These results were recently presented at the virtual…

Details

Assessing cancer diagnosis in children with birth defects

Scientific studies suggest that children with birth defects are at increased risk of cancer. However, it has not been assessed whether the type of cancer, the age at which they are diagnosed or the extent of cancer spread at the time of diagnosis, is different for children with birth defects compared to children without birth…

Details

About 30 Million Euros for excellent research

The German Research Foundation (DFG) has approved a new proposal for a collaborative research centre (CRC) under the leadership of the Institute for Experimental Cardiovascular Medicine (IEKM) at the University Heart Centre Freiburg · Bad Krozingen. The CRC 1425 «The heterocellular nature of cardiac lesions: Identities, interactions, implications» will be funded by the DFG with…

Details

Researchers develop new method to map cholesterol metabolism in brain

A team of researchers led by Swansea University have developed new technology to monitor cholesterol in brain tissue which could uncover its relation to neurodegenerative disease and pave the way for the development of new treatments. The research, published in the Proceedings of the National Academy of Sciences of the USA, shows the major locations…

Details

When COVID-19 meets flu season

CHICAGO — As if the COVID-19 pandemic isn’t scary enough, the flu season is not far away. How severe will the flu season be as it converges with the COVID-19 outbreak? What can we do to prepare? Dr. Benjamin Singer, a Northwestern Medicine pulmonologist who treats COVID-19 patients in the intensive care unit, outlines the…

Details

Key grant positions USC as leader in dental and craniofacial tissue regeneration

THE STUDIES SEEM LIKE something straight out of science fiction. There’s one focused on using stem cells to regenerate skull bone for patients with skull defects. Another aims to develop a hydrogel patch that could reduce scarring and regenerate hair follicles and sweat glands in burn victims. Another looks to create a transdermal patch that…

Details